Prof. Dr. Burkert Pieske

Prof. Burkert Pieske, MD: Primary and Secondary Outcomes of PARALLAX

Practical Cardiology

Prof. Burkert Pieske, MD: Sacubitril/Valsartan in HFpEF

Practical Cardiology

ESC 2020 Discussion: The PARALLAX Trial — Prof Burkert Pieske & Dr Harriette Van Spall

Long Covid: „Corona greift die Herzen an!“ | Prof. Dr. Burkert Pieske bei Viertel nach Acht

BILD

PieskeSenni

Burkert Mathias PIESKE (Austria): the Aldo-DHF study

ESC TV at ESC Congress 2020 - PARALLAX (Investigator)

European Society of Cardiology

🔴 Viertel nach Acht – 25. August 2022 | u.a. mit Dr. Gunter Frank, Prof. Dr. Burkert Pieske

BILD

Importance of extensive revascularisation and timing of MCS - EuroPCR 2021

PCR

Are You At Risk Of Having A Heart Attack? Dr. Brad Dibble, a cardiologist, explores this question.

PACE Cardiology

PARAGON-HF: Is There a Role for the ARNI in HFpEF?

ESC TV at Heart Failure 2018 - The new HFA definition of HFpEF

European Society of Cardiology

Safety in Surgery

Gastro University

Lessons in Bronchiectasis - Professor Pierluigi Ciet and Professor Harm Tiddens (31.07.24)

EMBARC Registry

Cardiovascular Research Onlife - Opportunities for discovery research

European Society of Cardiology

Sacubitril/Valsartan and Frailty in HFpEF in PARAGON-HF | ESC Congress 2022

American College of Cardiology